0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Orally Disintegrating Tablet Excipient Market Research Report 2026
Published Date: 2026-03-03
|
Report Code: QYRE-Auto-2G510
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Orally Disintegrating Tablet Excipient Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Orally Disintegrating Tablet Excipient Market Research Report 2026

Code: QYRE-Auto-2G510
Report
2026-03-03
Pages:127
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Orally Disintegrating Tablet Excipient Market Size

The global Orally Disintegrating Tablet Excipient market was valued at US$ 18390 million in 2025 and is anticipated to reach US$ 23320 million by 2032, at a CAGR of 3.5% from 2026 to 2032.

Orally Disintegrating Tablet Excipient Market

Orally Disintegrating Tablet Excipient Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Orally Disintegrating Tablet Excipient competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.
McePharma (Vivesa holding) was the global greatest company in Orally Disintegrating Tablet Excipient industry, with the revenue market Share of 3% , followed by BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical.APAC is the largest Orally Disintegrating Tablet Excipient market with about 30% market share. Americas is follower, accounting for about 27% market share.
This report delivers a comprehensive overview of the global Orally Disintegrating Tablet Excipient market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Orally Disintegrating Tablet Excipient. The Orally Disintegrating Tablet Excipient market size, estimates, and forecasts are provided in terms of sales volume (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Orally Disintegrating Tablet Excipient market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Orally Disintegrating Tablet Excipient manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Orally Disintegrating Tablet Excipient Market Report

Report Metric Details
Report Name Orally Disintegrating Tablet Excipient Market
Accounted market size in 2025 US$ 18390 million
Forecasted market size in 2032 US$ 23320 million
CAGR 3.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Binders
  • Glidents
  • Diluents
  • Disintegrants
  • Others
by Application
  • Anti-Psychotics Drug
  • Anti-Epileptics Drug
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, McePharma (Vivesa holding), Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Orally Disintegrating Tablet Excipient manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Orally Disintegrating Tablet Excipient sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Orally Disintegrating Tablet Excipient Market growing?

Ans: The Orally Disintegrating Tablet Excipient Market witnessing a CAGR of 3.5% during the forecast period 2026-2032.

What is the Orally Disintegrating Tablet Excipient Market size in 2032?

Ans: The Orally Disintegrating Tablet Excipient Market size in 2032 will be US$ 23320 million.

What is the McePharma (Vivesa holding), BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin Etsu, Fuji Chemical Industries, Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical share in Orally Disintegrating Tablet Excipient Market?

Ans: McePharma (Vivesa holding) was the global greatest company in Orally Disintegrating Tablet Excipient industry, with the revenue market Share of 3% , followed by BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical.

What is the Orally Disintegrating Tablet Excipient Market share by region?

Ans: APAC is the largest Orally Disintegrating Tablet Excipient market with about 30% market share. Americas is follower, accounting for about 27% market share.

Who are the main players in the Orally Disintegrating Tablet Excipient Market report?

Ans: The main players in the Orally Disintegrating Tablet Excipient Market are BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, McePharma (Vivesa holding), Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical

What are the Application segmentation covered in the Orally Disintegrating Tablet Excipient Market report?

Ans: The Applications covered in the Orally Disintegrating Tablet Excipient Market report are Anti-Psychotics Drug, Anti-Epileptics Drug, Others

What are the Type segmentation covered in the Orally Disintegrating Tablet Excipient Market report?

Ans: The Types covered in the Orally Disintegrating Tablet Excipient Market report are Binders, Glidents, Diluents, Disintegrants, Others

1 Orally Disintegrating Tablet Excipient Market Overview
1.1 Product Definition
1.2 Orally Disintegrating Tablet Excipient by Type
1.2.1 Global Orally Disintegrating Tablet Excipient Market Value by Type: 2025 vs 2032
1.2.2 Binders
1.2.3 Glidents
1.2.4 Diluents
1.2.5 Disintegrants
1.2.6 Others
1.3 Orally Disintegrating Tablet Excipient by Application
1.3.1 Global Orally Disintegrating Tablet Excipient Market Value by Application: 2025 vs 2032
1.3.2 Anti-Psychotics Drug
1.3.3 Anti-Epileptics Drug
1.3.4 Others
1.4 Global Orally Disintegrating Tablet Excipient Market Size Estimates and Forecasts
1.4.1 Global Orally Disintegrating Tablet Excipient Revenue 2021–2032
1.4.2 Global Orally Disintegrating Tablet Excipient Sales 2021–2032
1.4.3 Global Orally Disintegrating Tablet Excipient Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Orally Disintegrating Tablet Excipient Market Competition by Manufacturers
2.1 Global Orally Disintegrating Tablet Excipient Sales Market Share by Manufacturers (2021–2026)
2.2 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Orally Disintegrating Tablet Excipient Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Orally Disintegrating Tablet Excipient, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Orally Disintegrating Tablet Excipient, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Orally Disintegrating Tablet Excipient, Product Types and Applications
2.7 Global Key Manufacturers of Orally Disintegrating Tablet Excipient, Date of Entry into the Industry
2.8 Global Orally Disintegrating Tablet Excipient Market Competitive Situation and Trends
2.8.1 Global Orally Disintegrating Tablet Excipient Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Orally Disintegrating Tablet Excipient Players Market Share by Revenue
2.8.3 Global Orally Disintegrating Tablet Excipient Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Orally Disintegrating Tablet Excipient Market Scenario by Region
3.1 Global Orally Disintegrating Tablet Excipient Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Orally Disintegrating Tablet Excipient Sales by Region: 2021–2032
3.2.1 Global Orally Disintegrating Tablet Excipient Sales by Region: 2021–2026
3.2.2 Global Orally Disintegrating Tablet Excipient Sales by Region: 2027–2032
3.3 Global Orally Disintegrating Tablet Excipient Revenue by Region: 2021–2032
3.3.1 Global Orally Disintegrating Tablet Excipient Revenue by Region: 2021–2026
3.3.2 Global Orally Disintegrating Tablet Excipient Revenue by Region: 2027–2032
3.4 North America Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
3.4.1 North America Orally Disintegrating Tablet Excipient Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Orally Disintegrating Tablet Excipient Sales by Country (2021–2032)
3.4.3 North America Orally Disintegrating Tablet Excipient Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
3.5.1 Europe Orally Disintegrating Tablet Excipient Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Orally Disintegrating Tablet Excipient Sales by Country (2021–2032)
3.5.3 Europe Orally Disintegrating Tablet Excipient Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Orally Disintegrating Tablet Excipient Market Facts & Figures by Region
3.6.1 Asia Pacific Orally Disintegrating Tablet Excipient Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Orally Disintegrating Tablet Excipient Sales by Region (2021–2032)
3.6.3 Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
3.7.1 Latin America Orally Disintegrating Tablet Excipient Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Orally Disintegrating Tablet Excipient Sales by Country (2021–2032)
3.7.3 Latin America Orally Disintegrating Tablet Excipient Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
3.8.1 Middle East and Africa Orally Disintegrating Tablet Excipient Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2021–2032)
3.8.3 Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Orally Disintegrating Tablet Excipient Sales by Type (2021–2032)
4.1.1 Global Orally Disintegrating Tablet Excipient Sales by Type (2021–2026)
4.1.2 Global Orally Disintegrating Tablet Excipient Sales by Type (2027–2032)
4.1.3 Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2021–2032)
4.2 Global Orally Disintegrating Tablet Excipient Revenue by Type (2021–2032)
4.2.1 Global Orally Disintegrating Tablet Excipient Revenue by Type (2021–2026)
4.2.2 Global Orally Disintegrating Tablet Excipient Revenue by Type (2027–2032)
4.2.3 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2021–2032)
4.3 Global Orally Disintegrating Tablet Excipient Price by Type (2021–2032)
5 Segment by Application
5.1 Global Orally Disintegrating Tablet Excipient Sales by Application (2021–2032)
5.1.1 Global Orally Disintegrating Tablet Excipient Sales by Application (2021–2026)
5.1.2 Global Orally Disintegrating Tablet Excipient Sales by Application (2027–2032)
5.1.3 Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2021–2032)
5.2 Global Orally Disintegrating Tablet Excipient Revenue by Application (2021–2032)
5.2.1 Global Orally Disintegrating Tablet Excipient Revenue by Application (2021–2026)
5.2.2 Global Orally Disintegrating Tablet Excipient Revenue by Application (2027–2032)
5.2.3 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2021–2032)
5.3 Global Orally Disintegrating Tablet Excipient Price by Application (2021–2032)
6 Key Companies Profiled
6.1 BASF
6.1.1 BASF Company Information
6.1.2 BASF Description and Business Overview
6.1.3 BASF Orally Disintegrating Tablet Excipient Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 BASF Orally Disintegrating Tablet Excipient Product Portfolio
6.1.5 BASF Recent Developments/Updates
6.2 JRS Pharma
6.2.1 JRS Pharma Company Information
6.2.2 JRS Pharma Description and Business Overview
6.2.3 JRS Pharma Orally Disintegrating Tablet Excipient Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 JRS Pharma Orally Disintegrating Tablet Excipient Product Portfolio
6.2.5 JRS Pharma Recent Developments/Updates
6.3 Roquette
6.3.1 Roquette Company Information
6.3.2 Roquette Description and Business Overview
6.3.3 Roquette Orally Disintegrating Tablet Excipient Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Roquette Orally Disintegrating Tablet Excipient Product Portfolio
6.3.5 Roquette Recent Developments/Updates
6.4 ABF Ingredients
6.4.1 ABF Ingredients Company Information
6.4.2 ABF Ingredients Description and Business Overview
6.4.3 ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 ABF Ingredients Orally Disintegrating Tablet Excipient Product Portfolio
6.4.5 ABF Ingredients Recent Developments/Updates
6.5 DFE Pharma
6.5.1 DFE Pharma Company Information
6.5.2 DFE Pharma Description and Business Overview
6.5.3 DFE Pharma Orally Disintegrating Tablet Excipient Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 DFE Pharma Orally Disintegrating Tablet Excipient Product Portfolio
6.5.5 DFE Pharma Recent Developments/Updates
6.6 Evonik
6.6.1 Evonik Company Information
6.6.2 Evonik Description and Business Overview
6.6.3 Evonik Orally Disintegrating Tablet Excipient Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Evonik Orally Disintegrating Tablet Excipient Product Portfolio
6.6.5 Evonik Recent Developments/Updates
6.7 Merck KGaA
6.7.1 Merck KGaA Company Information
6.7.2 Merck KGaA Description and Business Overview
6.7.3 Merck KGaA Orally Disintegrating Tablet Excipient Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Merck KGaA Orally Disintegrating Tablet Excipient Product Portfolio
6.7.5 Merck KGaA Recent Developments/Updates
6.8 Ashland
6.8.1 Ashland Company Information
6.8.2 Ashland Description and Business Overview
6.8.3 Ashland Orally Disintegrating Tablet Excipient Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Ashland Orally Disintegrating Tablet Excipient Product Portfolio
6.8.5 Ashland Recent Developments/Updates
6.9 Meggle Pharma
6.9.1 Meggle Pharma Company Information
6.9.2 Meggle Pharma Description and Business Overview
6.9.3 Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Meggle Pharma Orally Disintegrating Tablet Excipient Product Portfolio
6.9.5 Meggle Pharma Recent Developments/Updates
6.10 Shin-Etsu
6.10.1 Shin-Etsu Company Information
6.10.2 Shin-Etsu Description and Business Overview
6.10.3 Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Shin-Etsu Orally Disintegrating Tablet Excipient Product Portfolio
6.10.5 Shin-Etsu Recent Developments/Updates
6.11 Fuji Chemical Industries
6.11.1 Fuji Chemical Industries Company Information
6.11.2 Fuji Chemical Industries Description and Business Overview
6.11.3 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product Portfolio
6.11.5 Fuji Chemical Industries Recent Developments/Updates
6.12 McePharma (Vivesa holding)
6.12.1 McePharma (Vivesa holding) Company Information
6.12.2 McePharma (Vivesa holding) Description and Business Overview
6.12.3 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product Portfolio
6.12.5 McePharma (Vivesa holding) Recent Developments/Updates
6.13 Cargill Incorporated
6.13.1 Cargill Incorporated Company Information
6.13.2 Cargill Incorporated Description and Business Overview
6.13.3 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Cargill Incorporated Orally Disintegrating Tablet Excipient Product Portfolio
6.13.5 Cargill Incorporated Recent Developments/Updates
6.14 Daicel Corporation
6.14.1 Daicel Corporation Company Information
6.14.2 Daicel Corporation Description and Business Overview
6.14.3 Daicel Corporation Orally Disintegrating Tablet Excipient Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Daicel Corporation Orally Disintegrating Tablet Excipient Product Portfolio
6.14.5 Daicel Corporation Recent Developments/Updates
6.15 Anhui Sunhere Pharmaceutical
6.15.1 Anhui Sunhere Pharmaceutical Company Information
6.15.2 Anhui Sunhere Pharmaceutical Description and Business Overview
6.15.3 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product Portfolio
6.15.5 Anhui Sunhere Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Orally Disintegrating Tablet Excipient Industry Chain Analysis
7.2 Orally Disintegrating Tablet Excipient Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Orally Disintegrating Tablet Excipient Production Mode & Process Analysis
7.4 Orally Disintegrating Tablet Excipient Sales and Marketing
7.4.1 Orally Disintegrating Tablet Excipient Sales Channels
7.4.2 Orally Disintegrating Tablet Excipient Distributors
7.5 Orally Disintegrating Tablet Excipient Customer Analysis
8 Orally Disintegrating Tablet Excipient Market Dynamics
8.1 Orally Disintegrating Tablet Excipient Industry Trends
8.2 Orally Disintegrating Tablet Excipient Market Drivers
8.3 Orally Disintegrating Tablet Excipient Market Challenges
8.4 Orally Disintegrating Tablet Excipient Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Orally Disintegrating Tablet Excipient Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Orally Disintegrating Tablet Excipient Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Orally Disintegrating Tablet Excipient Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Orally Disintegrating Tablet Excipient Sales (K MT) of Key Manufacturers (2021–2026)
 Table 5. Global Orally Disintegrating Tablet Excipient Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Orally Disintegrating Tablet Excipient Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Orally Disintegrating Tablet Excipient Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Orally Disintegrating Tablet Excipient Average Price (USD/MT) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Orally Disintegrating Tablet Excipient, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Orally Disintegrating Tablet Excipient, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Orally Disintegrating Tablet Excipient, Product Types and Applications
 Table 12. Global Key Manufacturers of Orally Disintegrating Tablet Excipient, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Orally Disintegrating Tablet Excipient Companies by Tier (Tier 1, Tier 2, Tier 3), based on Orally Disintegrating Tablet Excipient Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Orally Disintegrating Tablet Excipient Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Orally Disintegrating Tablet Excipient Sales by Region (K MT), 2021–2026
 Table 18. Global Orally Disintegrating Tablet Excipient Sales Market Share by Region (2021–2026)
 Table 19. Global Orally Disintegrating Tablet Excipient Sales by Region (K MT), 2027–2032
 Table 20. Global Orally Disintegrating Tablet Excipient Sales Market Share by Region (2027–2032)
 Table 21. Global Orally Disintegrating Tablet Excipient Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2021–2026)
 Table 23. Global Orally Disintegrating Tablet Excipient Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2027–2032)
 Table 25. North America Orally Disintegrating Tablet Excipient Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Orally Disintegrating Tablet Excipient Sales by Country (K MT), 2021–2026
 Table 27. North America Orally Disintegrating Tablet Excipient Sales by Country (K MT), 2027–2032
 Table 28. North America Orally Disintegrating Tablet Excipient Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Orally Disintegrating Tablet Excipient Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Orally Disintegrating Tablet Excipient Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Orally Disintegrating Tablet Excipient Sales by Country (K MT), 2021–2026
 Table 32. Europe Orally Disintegrating Tablet Excipient Sales by Country (K MT), 2027–2032
 Table 33. Europe Orally Disintegrating Tablet Excipient Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Orally Disintegrating Tablet Excipient Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Orally Disintegrating Tablet Excipient Sales by Region (K MT), 2021–2026
 Table 37. Asia Pacific Orally Disintegrating Tablet Excipient Sales by Region (K MT), 2027–2032
 Table 38. Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Orally Disintegrating Tablet Excipient Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Orally Disintegrating Tablet Excipient Sales by Country (K MT), 2021–2026
 Table 42. Latin America Orally Disintegrating Tablet Excipient Sales by Country (K MT), 2027–2032
 Table 43. Latin America Orally Disintegrating Tablet Excipient Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Orally Disintegrating Tablet Excipient Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (K MT), 2021–2026
 Table 47. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (K MT), 2027–2032
 Table 48. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Orally Disintegrating Tablet Excipient Sales (K MT) by Type (2021–2026)
 Table 51. Global Orally Disintegrating Tablet Excipient Sales (K MT) by Type (2027–2032)
 Table 52. Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2021–2026)
 Table 53. Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2027–2032)
 Table 54. Global Orally Disintegrating Tablet Excipient Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Orally Disintegrating Tablet Excipient Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2021–2026)
 Table 57. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2027–2032)
 Table 58. Global Orally Disintegrating Tablet Excipient Price (USD/MT) by Type (2021–2026)
 Table 59. Global Orally Disintegrating Tablet Excipient Price (USD/MT) by Type (2027–2032)
 Table 60. Global Orally Disintegrating Tablet Excipient Sales (K MT) by Application (2021–2026)
 Table 61. Global Orally Disintegrating Tablet Excipient Sales (K MT) by Application (2027–2032)
 Table 62. Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2021–2026)
 Table 63. Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2027–2032)
 Table 64. Global Orally Disintegrating Tablet Excipient Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Orally Disintegrating Tablet Excipient Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2021–2026)
 Table 67. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2027–2032)
 Table 68. Global Orally Disintegrating Tablet Excipient Price (USD/MT) by Application (2021–2026)
 Table 69. Global Orally Disintegrating Tablet Excipient Price (USD/MT) by Application (2027–2032)
 Table 70. BASF Company Information
 Table 71. BASF Description and Business Overview
 Table 72. BASF Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 73. BASF Orally Disintegrating Tablet Excipient Product
 Table 74. BASF Recent Developments/Updates
 Table 75. JRS Pharma Company Information
 Table 76. JRS Pharma Description and Business Overview
 Table 77. JRS Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 78. JRS Pharma Orally Disintegrating Tablet Excipient Product
 Table 79. JRS Pharma Recent Developments/Updates
 Table 80. Roquette Company Information
 Table 81. Roquette Description and Business Overview
 Table 82. Roquette Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 83. Roquette Orally Disintegrating Tablet Excipient Product
 Table 84. Roquette Recent Developments/Updates
 Table 85. ABF Ingredients Company Information
 Table 86. ABF Ingredients Description and Business Overview
 Table 87. ABF Ingredients Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 88. ABF Ingredients Orally Disintegrating Tablet Excipient Product
 Table 89. ABF Ingredients Recent Developments/Updates
 Table 90. DFE Pharma Company Information
 Table 91. DFE Pharma Description and Business Overview
 Table 92. DFE Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 93. DFE Pharma Orally Disintegrating Tablet Excipient Product
 Table 94. DFE Pharma Recent Developments/Updates
 Table 95. Evonik Company Information
 Table 96. Evonik Description and Business Overview
 Table 97. Evonik Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 98. Evonik Orally Disintegrating Tablet Excipient Product
 Table 99. Evonik Recent Developments/Updates
 Table 100. Merck KGaA Company Information
 Table 101. Merck KGaA Description and Business Overview
 Table 102. Merck KGaA Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 103. Merck KGaA Orally Disintegrating Tablet Excipient Product
 Table 104. Merck KGaA Recent Developments/Updates
 Table 105. Ashland Company Information
 Table 106. Ashland Description and Business Overview
 Table 107. Ashland Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 108. Ashland Orally Disintegrating Tablet Excipient Product
 Table 109. Ashland Recent Developments/Updates
 Table 110. Meggle Pharma Company Information
 Table 111. Meggle Pharma Description and Business Overview
 Table 112. Meggle Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 113. Meggle Pharma Orally Disintegrating Tablet Excipient Product
 Table 114. Meggle Pharma Recent Developments/Updates
 Table 115. Shin-Etsu Company Information
 Table 116. Shin-Etsu Description and Business Overview
 Table 117. Shin-Etsu Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 118. Shin-Etsu Orally Disintegrating Tablet Excipient Product
 Table 119. Shin-Etsu Recent Developments/Updates
 Table 120. Fuji Chemical Industries Company Information
 Table 121. Fuji Chemical Industries Description and Business Overview
 Table 122. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 123. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product
 Table 124. Fuji Chemical Industries Recent Developments/Updates
 Table 125. McePharma (Vivesa holding) Company Information
 Table 126. McePharma (Vivesa holding) Description and Business Overview
 Table 127. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 128. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product
 Table 129. McePharma (Vivesa holding) Recent Developments/Updates
 Table 130. Cargill Incorporated Company Information
 Table 131. Cargill Incorporated Description and Business Overview
 Table 132. Cargill Incorporated Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 133. Cargill Incorporated Orally Disintegrating Tablet Excipient Product
 Table 134. Cargill Incorporated Recent Developments/Updates
 Table 135. Daicel Corporation Company Information
 Table 136. Daicel Corporation Description and Business Overview
 Table 137. Daicel Corporation Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 138. Daicel Corporation Orally Disintegrating Tablet Excipient Product
 Table 139. Daicel Corporation Recent Developments/Updates
 Table 140. Anhui Sunhere Pharmaceutical Company Information
 Table 141. Anhui Sunhere Pharmaceutical Description and Business Overview
 Table 142. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 143. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product
 Table 144. Anhui Sunhere Pharmaceutical Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Orally Disintegrating Tablet Excipient Distributors List
 Table 148. Orally Disintegrating Tablet Excipient Customers List
 Table 149. Orally Disintegrating Tablet Excipient Market Trends
 Table 150. Orally Disintegrating Tablet Excipient Market Drivers
 Table 151. Orally Disintegrating Tablet Excipient Market Challenges
 Table 152. Orally Disintegrating Tablet Excipient Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Orally Disintegrating Tablet Excipient
 Figure 2. Global Orally Disintegrating Tablet Excipient Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Orally Disintegrating Tablet Excipient Market Share by Type: 2025 & 2032
 Figure 4. Binders Product Picture
 Figure 5. Glidents Product Picture
 Figure 6. Diluents Product Picture
 Figure 7. Disintegrants Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Orally Disintegrating Tablet Excipient Market Value by Application (US$ Million), 2021–2032
 Figure 10. Global Orally Disintegrating Tablet Excipient Market Share by Application: 2025 & 2032
 Figure 11. Anti-Psychotics Drug
 Figure 12. Anti-Epileptics Drug
 Figure 13. Others
 Figure 14. Global Orally Disintegrating Tablet Excipient Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Orally Disintegrating Tablet Excipient Market Size (US$ Million), 2021–2032
 Figure 16. Global Orally Disintegrating Tablet Excipient Sales (K MT), 2021–2032
 Figure 17. Global Orally Disintegrating Tablet Excipient Average Price (USD/MT), 2021–2032
 Figure 18. Orally Disintegrating Tablet Excipient Report Years Considered
 Figure 19. Orally Disintegrating Tablet Excipient Sales Share by Manufacturers in 2025
 Figure 20. Global Orally Disintegrating Tablet Excipient Revenue Share by Manufacturers in 2025
 Figure 21. Top 5 and Top 10 Global Orally Disintegrating Tablet Excipient Players: Market Share by Revenue in Orally Disintegrating Tablet Excipient in 2025
 Figure 22. Orally Disintegrating Tablet Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 23. Global Orally Disintegrating Tablet Excipient Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 24. North America Orally Disintegrating Tablet Excipient Sales Market Share by Country (2021–2032)
 Figure 25. North America Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2021–2032)
 Figure 26. U.S. Orally Disintegrating Tablet Excipient Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Canada Orally Disintegrating Tablet Excipient Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Country (2021–2032)
 Figure 29. Europe Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2021–2032)
 Figure 30. Germany Orally Disintegrating Tablet Excipient Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. France Orally Disintegrating Tablet Excipient Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. U.K. Orally Disintegrating Tablet Excipient Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Italy Orally Disintegrating Tablet Excipient Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Russia Orally Disintegrating Tablet Excipient Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Asia Pacific Orally Disintegrating Tablet Excipient Sales Market Share by Region (2021–2032)
 Figure 36. Asia Pacific Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2021–2032)
 Figure 37. China Orally Disintegrating Tablet Excipient Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Japan Orally Disintegrating Tablet Excipient Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. South Korea Orally Disintegrating Tablet Excipient Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. India Orally Disintegrating Tablet Excipient Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Australia Orally Disintegrating Tablet Excipient Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. China Taiwan Orally Disintegrating Tablet Excipient Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Indonesia Orally Disintegrating Tablet Excipient Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Thailand Orally Disintegrating Tablet Excipient Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Malaysia Orally Disintegrating Tablet Excipient Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Latin America Orally Disintegrating Tablet Excipient Sales Market Share by Country (2021–2032)
 Figure 47. Latin America Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2021–2032)
 Figure 48. Mexico Orally Disintegrating Tablet Excipient Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Brazil Orally Disintegrating Tablet Excipient Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Argentina Orally Disintegrating Tablet Excipient Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share by Country (2021–2032)
 Figure 52. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2021–2032)
 Figure 53. Turkey Orally Disintegrating Tablet Excipient Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Saudi Arabia Orally Disintegrating Tablet Excipient Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. UAE Orally Disintegrating Tablet Excipient Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Global Sales Market Share of Orally Disintegrating Tablet Excipient by Type (2021–2032)
 Figure 57. Global Revenue Market Share of Orally Disintegrating Tablet Excipient by Type (2021–2032)
 Figure 58. Global Orally Disintegrating Tablet Excipient Price (USD/MT) by Type (2021–2032)
 Figure 59. Global Sales Market Share of Orally Disintegrating Tablet Excipient by Application (2021–2032)
 Figure 60. Global Revenue Market Share of Orally Disintegrating Tablet Excipient by Application (2021–2032)
 Figure 61. Global Orally Disintegrating Tablet Excipient Price (USD/MT) by Application (2021–2032)
 Figure 62. Orally Disintegrating Tablet Excipient Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD